Abstract
Earlier concepts on the central action of procaine appear to have been limited to such untoward effects as restlessness, tremor and convulsion. Clinical experiences during the past decade, however, have revealed the usefulness of procaine as an analgesic when administered intravenously in a nontoxic dose. Bigelow and Harrison (1) evidenced this effect experimentally by the measurement of cutaneous pain threshold in human subjects. As Goodman (8) and Keats et al. (15) pointed out, such an action cannot be attributed, to the local action on sensory nerves, since the concentration of procaine in the peripheral tissue should be far below the minimal concentration necessary for nerve block. This naturally leads to the concept that the central nervous system should be responsible for the procaine analgesia.
Despite the wide clinical uses of intravenous procaine (9), there has been no investigator who found pharmacologically any distinct action of procaine on the central nervous system, except excitatory effects, in experimental animals. The present investigation is an attempt to discover depressant effects of procaine on the central nervous system in a nontoxic dose. The yielded results seem to be sufficient to convince us of the variegated central actions of this drug.
